-
Puma Biotechnology Inc (NASDAQ: PBYI) shares
jumped 83.5 percent to $69.35 as briefing documents for Wednesday Advisory Committee meeting are published to the FDA website.
The documents showed that neratinib performed better than Roche's trastuzumab in I-SPY2 trial, particularly in subgroup of
patients that were HRc negative. The briefing docs also showed that study 3004 met prespecified primary efficacy endpoint.
-
Nutraceutical Int'l Corp. (NASDAQ: NUTR) shares
surged 49.8 percent to $41.95 after the company agreed to be acquired by HGGC for $41.80 per share in cash.
-
Cheetah Mobile Inc (ADR) (NYSE: CMCM) shares gained
12.8 percent to $11.90 following strong earnings report.
-
Ferroglobe PLC (NASDAQ: GSM) shares surged 12.2
percent to $10.34 after the company posted a narrower-than-expected Q1 loss.
-
Nutanix Inc (NASDAQ: NTNX) jumped 11.4 percent to
$17.83. Nutanix disclosed the private cloud deployment of SAIC Volkswagen. Goldman Sachs upgraded Nutanix from Neutral to Buy.
-
Radius Health Inc (NASDAQ: RDUS) shares climbed
10.4 percent to $38.55 likely on the heels of concerning adverse side effect data from Amgen on its osteoporosis treatment.
-
Oclaro, Inc. (NASDAQ: OCLR) shares gained 9
percent to $9.26.
-
Yirendai Ltd - ADR (NYSE: YRD) shares rose 7.4
percent to $25.78 following Q1 earnings report.
-
Blackstone Group LP (NYSE: BX) climbed 5.3 percent to
$31.45. Citigroup upgraded Blackstone Group from Neutral to Buy.
-
Cree, Inc. (NASDAQ: CREE) rose 5.2 percent to
$24.30. JMP Securities upgraded Cree from Market Perform to Market Outperform.
-
GNC Holdings Inc (NYSE: GNC) shares gained 4.7
percent to $7.62 following announcement of Nutraceutical acquisition.
-
Booz Allen Hamilton Holding Corporation (NYSE: BAH) climbed 4.5 percent to $37.56 as the company posted better-than-expected
results for its fourth quarter.
-
Ciena Corporation (NYSE: CIEN) shares rose 4.1
percent to $23.89. Stifel Nicolaus upgraded Ciena from Hold to Buy.
-
Genesco Inc. (NYSE: GCO) shares surged 3.4 percent
to $46.60. B. Riley upgraded Genesco Inc from Neutral to Buy.
-
Carvana Co (NYSE: CVNA) rose 3.3 percent to $11.77.
Craig-Hallum initiated coverage on Carvana with a Buy rating.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.